Cell turnover in human seminal vesicles and the prostate: An immunohistochemical study

Prostate Cancer and Prostatic Diseases

Volumn 2, Issue 4, 1999, Pages 200-203

  Pannek, J ^a   Berges, R R ^b   Sauvageot, J ^a   Lecksell, K L ^a   Epstein, J I ^a   Partin, A W ^a  

^a DEPARTMENT OF PATHOLOGY   (United States)

^b RUHR UNIVERSITY BOCHUM   (Germany)

Author keywords

Apoptosis; Cell kinetics; Prostate; Seminal vesicles

Indexed keywords

ANDROGEN; KI 67 ANTIGEN; PROTEIN BCL 2; TRANSFORMING GROWTH FACTOR BETA;

ACCESSORY SEX ORGAN; ADULT; AGED; APOPTOSIS; ARTICLE; CELL KINETICS; CELL PROLIFERATION; CELL RENEWAL; HORMONE DEPENDENCE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; PRIORITY JOURNAL; PROSTATE; SEMINAL VESICLE; TISSUE GROWTH;

EID: 0033381213     PISSN: 13657852     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.pcan.4500315     Document Type: Article

References (27)

1. Luke MC, Coffey DS. The male sex accessory tissues. In: Knobil E & Neill JD (eds). The Physiology of Reproduction. Raven Press: New York, 1994, pp 1435-1487.
2. Godley PA. Prostate cancer screening: promise and peril - a review. Cancer Detect Prevent 1999; 23: 316-324.
3. Dalgaard JB, Giertsen JC. Primary carcinoma of the seminal vesicle. Case and survey. Acta Pathol Microbiol Scand 1956; 39: 255-267.
4. Zenklusen HR, Weymuth G, Rist M, Muhatsch MJ. Carcinosarcoma of the prostate in combination with andenocarcinoma of the seminal vesicle: a case report with immunohistochemical analysis and review of the literature. Cancer 1990; 66: 998-1001.
5. Ohmori T et al. CA 125-producing adenocarcinoma of the seminal vesicle. Pathol Int 1994; 44: 333-337.
6. Raff MC. Social controls on cell survival and cell depth. Nature 1992; 256: 396-400.
7. Kerr JFR, Wyllie AH, Currie AR. Apoptosis: a basic biological phenomenon with wide ranging implications in tissue kinetics. Br J Cancer 1972; 26: 239-257.
8. Bursch W, Oberhammer F, Schulte-Hermann R. Cell death by apoptosis and its protective role against disease. Trends Pharmac Sci 1992; 13: 245-251.
9. Roberts RA et al. Dosing-induced stress causes hepatocytc apoptosis in rats primed by the rodent nongenotoxic hepatocarcinogen cyproteron acetate. Toxicol Appl Pharmac 1995; 135: 192-199.
10. Liukkonen TJ et al. Expression of MIB-1, mitotic index and S-phase fraction as indicators of cell proliferation in superficial bladder cancer. Urol Res 1996; 24: 61-66.
11. 1 on proliferation and death of rat prostatic cells. Endocrinology 1990; 127: 2963-2968.
12. Reed JC. Bcl-2 and the regulation of programmed cell death. J Cell Biol 1994; 124: 1-6.
13. Gavrieli Y, Sherman Y, Ben-Sasson SA. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol 1992; 119: 493-501.
14. 1 and bcl-2 expression. Int J Cancer 1996; 69: 357-363.
15. Kyprianou N, Huacheng T, Jacobs SC. Apoptotic versus proliferative activities in human benign prostatic hyperplasia. Hum Pathol 1996; 27: 668-675.
16. Goldsworthy TL, Conolly RB, Fransson-Steen R. Apoptosis and cancer risk assessment. Mut Res 1996; 365: 71-90.
17. Aihara M et al. The frequency of apoptosis correlates with the prognosis of Gleason grade in adenocarcinoma of the prostate. Cancer 1995; 75: 522-529.
18. Berges RR et al. Implication of cell kinetic changes during progression of human prostatic cancer. Clin Cancer Res 1995; 1: 473-480.
19. Claus S, Berges R, Senge T, Schulze H. Cell kinetic in epithelium and stroma of benign prostatic hyperplasia. J Urol 1997; 158: 217-221.
20. Kyprianou N, Isaacs JT. Activation of programmed cell death in the rat ventral prostate after castration. Endocrinology 1988; 122: 552-562.
21. Sutkowski DM et al. Interaction of epidermal growth factor and transforming growth factor β in human prostatic epithelial cells in culture. Prostate 1992; 21: 133-143.
22. Colombel M et al. Detection of the apoptosis suppressing oncoprotein bcl-2 in hormone refractory human prostate cancers. Am J Pathol 1993; 143: 390-400.
23. Preston-Martin S et al. Increased cell division is a cause of human cancer. Cancer Res 1990; 50: 7415-7421.
24. Chang WC, Chapkin RS, Lupton JR. Predictive value of proliferation, differentiation and apoptosis as intermediate markers for colon tumorgenesis. Carcinogenesis 1997; 18: 721-730.
25. Ward JM et al. Cell proliferation not associated with carcinogenesis in rodents and humans. Environ Health Perspect 1993; 101(Suppl 5): 125-136.
26. Grasl-Kraupp B et al. Inherent increase of apoptosis in liver tumors: implications for carcinogenesis and tumor regression. Hepatology 1997; 25: 906-912.
27. Potten CS, Li YQ, Connor PJO, Winton DJ. A possible explanation for the differential cancer incidence in the intestine, based on distribution of the cytotoxic effects of carcinogens in the murine large bowel. Carcinogenesis 1992; 13: 2305-2313.